A
Artemis Global Life Sciences Ltd((Merged)
AGLSL NSE
This stock has been delisted or merged and is no longer actively traded.
Artemis Global Life Sciences Ltd((Merged)
DelistedNSE: AGLSL
This stock has been delisted or merged and is no longer actively traded.
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Stock is trading at 1.12 times its book value
Weaknesses
2- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 9.65% over last 3 years.
Growth Rate
Revenue Growth
9%
Net Income Growth
-21%
Quarterly Results
| Particulars | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 119 | 126 | 120 | 137 | 126 | 141 | 139 | 140 | 136 |
| Expenses | 109 | 114 | 110 | 112 | 115 | 124 | 122 | 122 | 121 |
| Operating Profit | 10.49 | 12.34 | 10.53 | 25.57 | 11.72 | 17.07 | 17.12 | 17.91 | 14.8 |
| OPM % | 8.79% | 9.78% | 8.76% | 18.62% | 9.27% | 12.12% | 12.31% | 12.78% | 10.91% |
| Other Income | 1.13 | 1.28 | 0.9 | 1.06 | 1.17 | 0.89 | 0.63 | 1.31 | 0.59 |
| Interest | 2.07 | 2.62 | 2.14 | 2.59 | 2.03 | 2.99 | 3.1 | 2.88 | 3.28 |
| Depreciation | 4.35 | 4.94 | 4.77 | 4.74 | 4.9 | 4.96 | 5.02 | 5.2 | 5.45 |
| PBT | 5.2 | 6.06 | 4.52 | 19.3 | 5.96 | 10.01 | 9.63 | 11.14 | 6.66 |
| Tax % | 37.69% | 38.61% | 27.21% | 17.2% | 38.59% | 36.56% | 49.01% | 50.9% | 35.89% |
| Net Profit | 3.24 | 3.73 | 3.3 | 15.97 | 3.65 | 6.35 | 4.91 | 5.47 | 4.27 |
| EPS in Rs | 0.49 | 0.56 | 0.5 | 2.41 | 0.55 | 0.96 | 0.74 | 0.83 | 0.65 |
Profit & Loss
| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | TTM |
|---|---|---|---|---|
| Sales | 463 | 503 | 547 | 556 |
| Expenses | 411 | 443 | 481 | 489 |
| Operating Profit | 52 | 60 | 66 | 67 |
| OPM % | 11% | 12% | 12% | 12% |
| Other Income | 5 | 3 | 2 | 3 |
| Interest | 9 | 9 | 11 | 12 |
| Depreciation | 15 | 19 | 20 | 21 |
| PBT | 33 | 35 | 37 | 37 |
| Tax % | 17% | 25% | 45% | — |
| Net Profit | 27 | 26 | 20 | 21 |
| EPS in Rs | 4.1 | 3.97 | 3.1 | 3.18 |
| Div. Payout % | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2017 | Mar 2018 | Mar 2019 |
|---|---|---|---|
| Equity Capital | 13 | 13 | 13 |
| Reserves | 234 | 260 | 280 |
| Borrowings | 94 | 91 | 76 |
| Other Liabilities | 129 | 133 | 185 |
| Total Liabilities | 469 | 497 | 554 |
| Fixed Assets | 326 | 352 | 381 |
| CWIP | 27 | 43 | 49 |
| Investments | 0 | 0 | 0 |
| Other Assets | 116 | 102 | 124 |
| Total Assets | 469 | 497 | 554 |
Cash Flow
| Particulars | Mar 2017 | Mar 2018 | Mar 2019 |
|---|---|---|---|
| Operating | 52 | 71 | 40 |
| Investing | -70 | -67 | -50 |
| Financing | 22 | -10 | 14 |
| Net Cash Flow | 4 | -5 | 5 |
| Free Cash Flow | -19 | 10 | -17 |
| CFO/OP | 103 | 121 | 76 |
Ratios
| Particulars | Mar 2017 | Mar 2018 | Mar 2019 |
|---|---|---|---|
| Debtor Days | 48 | 40 | 52 |
| Cash Conversion Cycle | 48 | 40 | 52 |
| Working Capital Days | -24 | -26 | -36 |
| ROCE % | — | 13% | 14% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Artemis Global Life Sciences Ltd((Merged) insights
48 extracted metrics + investor summaries across FY17–FY19.
Documents
3
Announcement under Regulation 30 (LODR)-Newspaper Publication
15 Oct 2019 - Notice published in the Newspaper - Intimation about the Record Date of the Composite Scheme of Amalgamation between Artemis Global Life Sciences Limited ('Company'), Artemis … 15 Oct 2019 - Notice published in the Newspaper - Intimation about the Record Date of the Composite Scheme of Amalgamation between Artemis Global Life Sciences Limited ('Company'), Artemis …
4
Announcement under Regulation 30 (LODR)-Newspaper Publication
15 Oct 2019 - Notice published in the Newspaper - Intimation about the Record Date of the Composite Scheme of Amalgamation between Artemis Global Life Sciences Limited ('Company'), Artemis … 15 Oct 2019 - Notice published in the Newspaper - Intimation about the Record Date of the Composite Scheme of Amalgamation between Artemis Global Life Sciences Limited ('Company'), Artemis …
5
Statement Of Investor Complaints For The Quarter Ended September 2019
15 Oct 2019 - No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter … 15 Oct 2019 - No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter …
Frequently Asked Questions about Artemis Global Life Sciences Ltd((Merged)
What does Artemis Global Life Sciences Ltd((Merged) do?
Artemis Global Life Sciences is engaged in Healthcare Services.
Where is Artemis Global Life Sciences Ltd((Merged) (AGLSL) listed?
Artemis Global Life Sciences Ltd((Merged) trades as AGLSL on the NSE.
Company Information
Artemis Global Life Sciences is engaged in Healthcare Services.
Website aglsl.in
Face Value ₹ 2
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/AGLSL.md for Artemis Global Life Sciences Ltd((Merged): company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.